Article (Scientific journals)
Les traitements biologiques en rhumatologie
Von Frenckell, Christian; Malaise, Michel
2009In Revue Médicale de Liège, 64 (5-6), p. 293-300
Peer reviewed
 

Files


Full Text
Malaise_2009_RevMedLiege_293-300.pdf
Publisher postprint (429.12 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Antibodies, Monoclonal; Antirheumatic Agents; Immunoglobulin Fab Fragments; Immunoglobulin G; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; adalimumab; golimumab; infliximab
Abstract :
[en] Biological therapies consisting of monoclonal antibodies and soluble receptors have revolutionized the care of rheumatologic patients. These therapies ensued from a better understanding of the physiopathology of rheumatologic disorders. Most of the latter have been concerned: rheumatoid arthritis (for about 10 years), psoriatic arthritis and ankylosing spondilitys (for more or less five years). Rheumatology was among the first disciplines to make use of these advances; it continues to benefit from the results of intense research efforts. These developments request from clinicians an increased expertise in immunology.
Disciplines :
Rheumatology
Author, co-author :
Von Frenckell, Christian ;  Université de Liège - ULiège > Rhumatologie
Malaise, Michel ;  Université de Liège - ULiège > Département des sciences cliniques > Rhumatologie
Language :
French
Title :
Les traitements biologiques en rhumatologie
Alternative titles :
[en] Biological therapies in rheumatology
Publication date :
2009
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Hopital de Baviere, Liège, Belgium
Volume :
64
Issue :
5-6
Pages :
293-300
Peer reviewed :
Peer reviewed
Additional URL :
Available on ORBi :
since 20 September 2010

Statistics


Number of views
286 (17 by ULiège)
Number of downloads
714 (10 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0

Bibliography


Similar publications



Contact ORBi